>This study demonstrates individuals who received the Pfizer-BioNTech mRNA vaccine have different kinetics of antibody levels compared to patients who had been infected with the SARS-CoV-2 virus, with higher initial levels but a much faster exponential decrease in the first group. The unvaxxed don’t need antibodies, once gone T cells and other parts of the immune system can handle repeat infections unlike the vaxxed.